aTyr Pharma, Inc.
NASDAQ: ATYR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sanjay S. Shukla
- Employees
- 56
- Headquarters
- San Diego, United States
- IPO year
- 2015
- Market cap
- $55.1M
- Website
- https://www.atyrpharma.com
Loading ATYR…
Loading profile data…Frequently asked questions about ATYR
What does aTyr Pharma, Inc. (ATYR) do?
aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, e...
Where does ATYR trade?
aTyr Pharma, Inc. (ATYR) trades on the NASDAQ Global Market.
What sector is ATYR in?
aTyr Pharma, Inc. (ATYR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of aTyr Pharma, Inc.?
Sanjay S. Shukla is the chief executive officer of aTyr Pharma, Inc. (ATYR).
Where is aTyr Pharma, Inc. headquartered?
aTyr Pharma, Inc. is headquartered in United States.
Does ATYR pay a dividend?
aTyr Pharma, Inc. (ATYR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATYR go public?
aTyr Pharma, Inc. (ATYR) completed its initial public offering in 2015.